GB 29 Plus Tablet contains a combination of Pregabalin 75 mg and Nortriptyline 10 mg, formulated for the management of neuropathic pain and certain mood disorders. Pregabalin, an anticonvulsant and analgesic agent, modulates calcium channels in the central nervous system, thereby reducing the release of neurotransmitters involved in pain signaling. Nortriptyline, a tricyclic antidepressant, inhibits the reuptake of norepinephrine and serotonin, enhancing their activity in the central nervous system and contributing to analgesic and mood-stabilizing effects. This combination is particularly effective in treating conditions such as diabetic neuropathy, postherpetic neuralgia, fibromyalgia, and chronic neuropathic pain, where both pain relief and mood improvement are desired. GB 29 Plus Tablet should be administered as prescribed by a healthcare professional, with dosage tailored to individual patient needs and tolerability. Common adverse effects may include dizziness, drowsiness, dry mouth, and gastrointestinal disturbances. Caution is advised in patients with a history of cardiac conditions, renal impairment, or those taking other central nervous system depressants. Regular monitoring is recommended to assess therapeutic response and detect any potential side effects. GB 29 Plus Tablet offers a synergistic approach to neuropathic pain management, improving patient quality of life through combined pharmacological actions.